Roundup: Strata Oncology, Genomenon, Gilbert Family Foundation, More

Spring is always a busy time for Michigan’s innovation community, so let’s catch up on recent tech and entrepreneurial news below: —Last year, we reported on the Gilbert Family Foundation, a charitable organization founded by Quicken Loans chairman Dan Gilbert and his wife Jennifer, and its initiative to develop gene therapy treatments for neurofibromatosis 1 (NF1). … Continue reading “Roundup: Strata Oncology, Genomenon, Gilbert Family Foundation, More”

Why Investors Are Turning to the Midwest—and How to Keep them Coming

For decades, venture capital investors have targeted the East and West coasts to find and fund their next big startup growth company. The result? Two thirds of VC deals and dollars are currently, as of the first quarter of 2019, held in three states—California, New York, and Massachusetts—in three regions of the U.S. Trailing those … Continue reading “Why Investors Are Turning to the Midwest—and How to Keep them Coming”

Roundup: QL Demo Day, Millendo Therapeutics, Strata Oncology, More

—Millendo Therapeutics, an Ann Arbor-based biopharmaceutical company developing treatments for rare diseases, has initiated a Phase 2b/3 clinical study investigating livoletide (AZP-531) in patients with Prader-Willi syndrome. The study will evaluate the safety and efficacy of the drug on food-related behaviors—primarily hyperphagia, the excessive hunger which is a hallmark of the disease—in Prader-Willi patients. The … Continue reading “Roundup: QL Demo Day, Millendo Therapeutics, Strata Oncology, More”

Roundup: OptimizeRx, Parabricks, URC, Startup Detroit, ACM and More

The weather is finally starting to cool—I’m a fan of fall —but Michigan’s tech startups and entrepreneurs are still red-hot: they’re raising money, buying competitors and complementary companies, launching new products, and more. Read on for recent news about the state’s innovation community. —Rochester’s OptimizeRx, a digital health company focused on facilitating digital communication between … Continue reading “Roundup: OptimizeRx, Parabricks, URC, Startup Detroit, ACM and More”

Pfizer, Merck Lead Strata Oncology’s $26M Series B Round

In what company leaders describe as a “huge step,” Ann Arbor, MI-based precision medicine startup Strata Oncology this week closed a $26 million Series B investment round led by Pfizer Ventures and the Merck Global Health Innovation Fund. Other contributors to the round include Deerfield Management, Renaissance Venture Capital Fund, Arboretum Ventures, and Baird Capital. … Continue reading “Pfizer, Merck Lead Strata Oncology’s $26M Series B Round”

UT, Aurora Health Join Strata Oncology’s Free Genomic Testing Network

Ann Arbor, MI’s Strata Oncology launched in 2015 with a mission to help bring free tumor sequencing to as many patients as possible. To help accomplish that mission, the genomics startup has established the Strata Precision Oncology Network, a group of cancer centers collaborating to help boost access to precision medicine. Last month, Strata announced … Continue reading “UT, Aurora Health Join Strata Oncology’s Free Genomic Testing Network”

Roundup: NextChallenge Winners, Strata Oncology Trial, MCWT & More

What a long, strange year it’s been, with no shortage of news coming out of the technology sector. As we say goodbye to 2017, here’s a final roundup of innovation news from around the state: —Detroit cleantech incubator NextEnergy, in partnership with Denso, DTE Energy, and Wells Fargo, has named Ontario’s SmartCone as the winner of the … Continue reading “Roundup: NextChallenge Winners, Strata Oncology Trial, MCWT & More”

Strata Oncology, UCSF Partner to Offer $25M in Free Tumor Sequencing

Ann Arbor, MI-based Strata Oncology this week announced a new partnership with the University of California, San Francisco, to provide $25 million in free tumor sequencing nationwide for men with metastatic prostate cancer. Called StratifyProstate, the initiative aims to dramatically increase enrollment in relevant precision medicine trials, says Strata CEO Dan Rhodes. Despite the significant promise … Continue reading “Strata Oncology, UCSF Partner to Offer $25M in Free Tumor Sequencing”

Detroit Expansions, Tumor Sequencing, and More Local Innovation News

Here’s a look at innovation news from around Michigan: —Avomeen Analytical Services, a research and chemical testing lab based in Ann Arbor, was recently acquired by High Street Capital. The terms were not disclosed. The 22-person company, which launched in 2010, does R&D and chemical analysis for customers in a variety of sectors, including pharma, manufacturing, … Continue reading “Detroit Expansions, Tumor Sequencing, and More Local Innovation News”

Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More

If you blinked, you probably missed something this week in biotech. The nation’s biggest annual cancer meeting took place in Chicago, while biotech’s trade group held its annual confab in San Francisco. In Boston, there were more twists for a closely watched Duchenne muscular dystrophy drug and a setback for a high-profile drug for multiple … Continue reading “Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More”

Strata Oncology Closes $12M Round, Aims to Increase Tumor Sequencing

Ann Arbor, MI-based precision medicine startup Strata Oncology announced last week that it has raised a $12 million Series A round. Arboretum Ventures and Baird Capital led the financing, with participation from Michigan eLab, a returning investor. Strata is on a mission to make tumor sequencing for cancer patients more accessible. As personalized genetic therapies … Continue reading “Strata Oncology Closes $12M Round, Aims to Increase Tumor Sequencing”

Strata Oncology Receives $12,000,000 Series A Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4b0984cf-70e3-4ca6-8843-b25c98654287 Date 6/3/2016 Company Name Strata Oncology Mailing Address 8170 Jackson Road Ann Arbor, MI 48103 USA Company Description At Strata Oncology, our goal is to dramatically expand late stage cancer patients’ access to tumor sequencing and precision medicine trials and to accelerate the approval and availability of breakthrough cancer medicines. Website … Continue reading “Strata Oncology Receives $12,000,000 Series A Round”